Researchers have created an H5N1 avian influenza, or bird flu, vaccine that can be administered as a nasal spray. The influenza virus vector-based nasal spray vaccine platform was first developed ...

The presentations include post hoc analyses of clinical data prospectively collected from studies of diazepam nasal spray as an immediate-use seizure medication for treatment of episodes of frequent ...

Power Knot Ocean announced the installations of an LFC-200 biodigester aboard the expedition vessel Seaventure as well as the Mitsui Ocean Fuji. In a press release, the company said that the system on ...

Spray it ain’t so! It’s bad enough you’re brushing your teeth all wrong — now it turns out you’ve also been abusing your nasal spray. “I was yesterday years old when I learned there ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Centre for Virology, Vaccinology and Therapeutics (CVVT) have pioneered an influenza virus ...

--(BUSINESS WIRE)--Aerin Medical, Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of positive three-year results from VATRAC, a randomized ...

Selon l’ONG Bloom, qui vient de publier un rapport sur le sujet à l’occasion du sommet SOS Ocean, les chalutiers sont responsables de 90% de la destruction des fonds causée par la pêche française, ...

Milestone® Pharmaceuticals (NASDAQ:MIST) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its New Drug Application (NDA) for CARDAMYST™ ...

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a challenge for Milestone Pharmaceutical in its 22 years. Now the wait will ...

The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.

March 28 (Reuters) - Milestone Pharmaceuticals (MIST.O), opens new tab said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had ...